Title |
Seek COVER: using a disease proxy to rapidly develop and validate a personalized risk calculator for COVID-19 outcomes in an international network
|
---|---|
Published in |
BMC Medical Research Methodology, January 2022
|
DOI | 10.1186/s12874-022-01505-z |
Pubmed ID | |
Authors |
Ross D. Williams, Aniek F. Markus, Cynthia Yang, Talita Duarte-Salles, Scott L. DuVall, Thomas Falconer, Jitendra Jonnagaddala, Chungsoo Kim, Yeunsook Rho, Andrew E. Williams, Amanda Alberga Machado, Min Ho An, María Aragón, Carlos Areia, Edward Burn, Young Hwa Choi, Iannis Drakos, Maria Tereza Fernandes Abrahão, Sergio Fernández-Bertolín, George Hripcsak, Benjamin Skov Kaas-Hansen, Prasanna L. Kandukuri, Jan A. Kors, Kristin Kostka, Siaw-Teng Liaw, Kristine E. Lynch, Gerardo Machnicki, Michael E. Matheny, Daniel Morales, Fredrik Nyberg, Rae Woong Park, Albert Prats-Uribe, Nicole Pratt, Gowtham Rao, Christian G. Reich, Marcela Rivera, Tom Seinen, Azza Shoaibi, Matthew E. Spotnitz, Ewout W. Steyerberg, Marc A. Suchard, Seng Chan You, Lin Zhang, Lili Zhou, Patrick B. Ryan, Daniel Prieto-Alhambra, Jenna M. Reps, Peter R. Rijnbeek |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
United Kingdom | 3 | 19% |
Italy | 1 | 6% |
United States | 1 | 6% |
Spain | 1 | 6% |
Netherlands | 1 | 6% |
Colombia | 1 | 6% |
Unknown | 8 | 50% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 9 | 56% |
Scientists | 6 | 38% |
Practitioners (doctors, other healthcare professionals) | 1 | 6% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 59 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Master | 8 | 14% |
Student > Bachelor | 6 | 10% |
Researcher | 5 | 8% |
Student > Ph. D. Student | 4 | 7% |
Professor | 2 | 3% |
Other | 9 | 15% |
Unknown | 25 | 42% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 11 | 19% |
Nursing and Health Professions | 3 | 5% |
Pharmacology, Toxicology and Pharmaceutical Science | 2 | 3% |
Engineering | 2 | 3% |
Economics, Econometrics and Finance | 2 | 3% |
Other | 9 | 15% |
Unknown | 30 | 51% |